STAT

Opinion: He Jiankui, embryo editing, CCR5, the London patient, and jumping to conclusions

Nature is complicated, viruses are tricky, assumptions are dangerous — and He Jiankui's #CRISPR experiment on human embryos was, amazingly, even worse than I first thought.

When He Jiankui announced the birth of twin girls whose DNA he had modified when they were embryos using the CRISPR gene-editing tool, he justified his actions on the ground that he had given the two girls lifetime immunity from HIV infection. The Chinese scientist claimed that he had altered a gene called CCR5, which allows the AIDS-causing virus to infect an important class of cells in the human immune system.

Not only was He ethically wrong in doing this work, but its scientific basis was even weaker than generally recognized.

He’s experiment has been widely, roundly, scorchingly, and appropriately . The risks to the babies born nine months later were vastly higher than the benefits to them or to science; the informed consent process for their parents was deeply flawed; China’s legally required regulatory process had apparently been corrupted; the experiments had been wrongly kept secret; and a

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks